An alternate mechanism of glucocorticoid anti-proliferative effect: Promotion of a Th2 cytokine-secreting profile

Clinical Transplantation

Volumn 13, Issue 5, 1999, Pages 365-374

  Almawi, W Y ^a,c   Melemedjian, O K ^a   Rieder, M J ^b  

^a HAIGAZIAN UNIVERSITY   (Lebanon)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

Author keywords

Cytokines; Glucocorticoids; mRNA; T cells; Transplantation

Indexed keywords

ANTIINFLAMMATORY AGENT; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOKINE;

AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; INFLAMMATION; MACROPHAGE; MONOCYTE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANTI-INFLAMMATORY AGENTS; CYTOKINES; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; STEROIDS; TH2 CELLS;

EID: 0032822859     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.1999.130501.x     Document Type: Review

References (121)

1. HRICIK DE, ALMAWI WY, STROM TB. Trends in the use of glucocorticoids in renal transplantation. Transplantation 1994: 57: 979.
2. BOUMPAS DT, CHROUSOS GP, WILDER RL, CUPPS TR, BALOW JE. Glucocorticoids therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993: 119: 1198.
3. JEVNIKAR AM, SINGER GC, BRENNAN DC, XU H-W, RUBIN-KELLEY V. Dexamethasone prevents autoimmune nephritis and reduces renal expression of la but not costimulatory signals. Am J Pathol 1992: 141: 743.
4. HARDING SM, FREEDMAN SA. A comparison of oral and inhaled steroids in patients with chronic airway obstruction: features determining response. Thorax 1978: 33: 214.
5. RUDD R. Corticosteroids in chronic bronchitis. Br Med J 1984: 288: 1553.
6. ALMAWI WY, HESS DA, RIEDER MJ. Multiplicity of glucocorticoid action in inhibiting allograft rejection. Cell Transplant 1998: 7: 512.
7. BAUS M, ANDRIS F, DUBOIS PM, URBAIN J, LEO O. Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J Immunol 1996: 156: 4555.
8. PALIOGIANNI F, AHUJA SS, BALOW JP, BALOW JE, BOUMPAS DT. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through the IL-2 receptor. J Immunol 1993: 151: 4081.
9. ALMAWI WY, BEYHUM HN, RAHME AA, RIEDER MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukocyte Biol 1996: 66: 563.
10. MCFARLAND HF. Complexities in the treatment of autoimmune disease. Science 1996: 274: 2037.
11. ABBAS AK, MURPHY KM, SHER A. Functional diversity of helper T lymphocytes. Nature 1996: 383: 787.
12. ROMAGNANI S. Biology of human Th1 and Th2 cells. J Clin Immunol 1995: 15: 121.
13. MAGGI E, PARRONCHI P, MANETTI R, SIMONELLI C, PICCINNI M, RUCIU FS, DE CARLI M, RICCI M, ROMAGNANI S. Reciprocal regulatory effect of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992: 148: 2142.
14. SUTHANTHIRAN M, STROM TB. Immunobiology and immunopharmacology of organ allograft rejection. J Clin Immunol 1995: 15: 161.
15. MADDEN DR. The three dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995: 13: 587.
16. WANGE RL, SAMELSON LE. Complex complexes: signaling at the TCR. Immunity 1996: 5: 197.
17. BEYERS AD, SPRUYT LL, WILLIAMS AF. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD5. Proc Natl Acad Sci USA 1992: 89: 2945.
18. LINSLEY PS, BRADY W, URNES M, GROSMAIRE LS, DAMLE NK, LEDBETTER JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991: 174: 561.
19. JOSEPH SB, MINER KT, CROFT M. Augmentation of naive. Th1 and Th2 effector CD4 responses by IL-6, IL-1, and TNF. Eur J Immunol 1998: 28: 277.
20. LEDBETTER JA, IMBODEN JB, SCHIEVEN CL, GROSMAIRE LS, RABINOVITCH PS, LINDSTEN T, THOMPSON CB, JUNE CH. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 1990: 75: 1531.
21. FRASER JD, STRAUS D, WEISS A. Signal transduction events leading to T-cell lymphokine gene expression. Immunol Today 1993: 14: 357.
22. SPERLING AI, AUGER JA, EHST BD, RULIFSON IC, THOMPSON CB, BLUESTONE JA. CD28/B7 interaction deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J Immunol 1996: 157: 3909.
23. LASALLE JM, HAFFLER DA. T cell anergy. FASEB J 1994: 8: 601.
24. SCHWARTZ RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med 1996: 184: 1.
25. CANTRELL D. T cell antigen receptor signal transduction pathways. Annu Rev Immunol 1996: 14: 259.
26. KLAUSNER RD, SAMELSON LE. T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell 1991: 64: 857.
27. MARSHALL CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained signal-regulated kinase activation. Cell 1995: 80: 179.
28. LISCOVITCH M. Crosstalk among multiple signal-activated phospholipases. Trends Biochem Sci 1992: 17: 393.
29. PAWSON T. Protein modules and signalling networks. Nature 1995: 373: 573.
30. DOWNWARD J, GRAVES JD, WARNE PH, RAYTER S, CANTRELL DA. Stimulation of p21ras upon T-cell activation. Nature 1990: 346: 719.
31. RODRIGUEZ-VICIANA P, WARNE PH, DHAND R, VANHAESEBROECK B, GOUT I, FRY MJ, WATERFIELD MD, DOWNWARD J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994: 370: 527.
32. DESAI DM, NEWTON ME, KADLECEK T, WEISS A. Stimulation of the phosphatidyl inositol pathway can induce T cell activation. Nature 1990: 348: 66.
33. MAJERUS PW, ROSS TS, CUNNINCHAM TW, CALDWELL KK, BENNETT K, JEFFERSON A, BANSAL VS. Recent insights into phosphatidylinositol signaling. Cell 1990: 63: 459.
34. MANGER B, WEISS A, IMBODEN J, LAING T, STOBO JD. The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. Effect of stimulation with soluble or immobilized CD3 antibodies. J Immunol 1987: 139: 2755.
35. CLIPSTONE NA, CRABTREE GR. Identification of calcineurin as a key signaling enzyme in T lymphocyte activation. Nature 1992: 357: 695.
36. FRUMAN DA, KLEE CB, BIERER BE, BURAKOFF SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci USA 1992: 89: 3686.
37. ANGEL P, KARIN M. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochem Biophys Acta 1991: 1072: 129.
38. BLANK V, KOWILSKY P, ISRAEL A. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci 1992: 17: 135.
39. CONSTANT S, PFEIFER C, WOODARD A, PASQUALINI T, BOTTOMLY K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med 1996: 182: 1591.
40. KUNDIG TM, SHAHINIAN A, KAWAI K, MITTRUCKER HW, SEBZDA E, BACHMANN MF, MAK TW, OHASHI PS. Duration of TCR stimulation determines co-stimulatory requirements of T cells. Immunity 1996: 5: 41.
41. MONFAR M, BLENIS J. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone. Mol Endocrinol 1996: 10: 1107.
42. TOBENA R, HORIKAWA S, CALVO V, ALEMANY S. Interleukin-2 induces γ-S-adenosyl-L-methionine synthetase gene expression during T-lymphocyte activation. Biochem J 1996: 319: 929.
43. ALMAWI WY, HADRO ET, STROM TB. Evidence that glucocorticosteroid-mediated immunosuppressive effects do not involve altering second messenger function. Transplantation 1991: 52: 133.
44. ELLIOTT LH, LEVAY AK, SPARKS B, MILLER M, ROSZMAN TL. Dexamethasone and prostaglandin E2 modulate T-cell receptor signaling through a c-AMP independent mechanism. Cell Immunol 1996: 169: 117.
45. PERRETTI M, FLOWER RJ. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 1993: 150: 992.
46. PITZALIS C, PIPITONE N, BAJOCCHI C, HALL M, GOULDING N, LEE A, KINGSLEY C, LANCHBURY J, PANAYI G. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion. An additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol 1997: 158: 5007.
47. TESSIER P, AUDETTE M, CATTARUZZI P, MCCOLL SR. Upregulation by tumor necrosis factor-α of intracellular adhesion molecule-1 expression and function in synovial fibroblasts and its inhibition by glucocorticoids. Arth Rheumatol 1993: 11: 1528.
48. ALMAWI WY, LIPMAN ML, STEVENS AC, ZANKER B, HADRO ET, STROM TB. Abrogation of glucocorticoisteroid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. J Immunol 1991: 146: 3523.
49. MORI A, KAMINUMA O, SUKO M, INOUE S, OHMURA T, HOSHINO A, ASAKURA Y, MIYAZAWA K, YOKOTA T, OKUMURA Y, ITO K, OKUDAIRA H. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 1997: 89: 2891.
50. AUPHAN N, DIDONATO JA, ROSETTE C, HELMBERG A, KARIN M. Immune-suppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995: 270: 286.
51. ZITNIK RJ, WHITING NL, ELTAS JA. Glucocortiocoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms. Am J Resp Mol Biol 1994: 10: 643.
52. CROXTALL JD, CHOUDHURY Q, TOKUMOTO H, FLOWER RJ. Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids inhibit G protein-dependent activation of cPLA2 activity. Biochem Pharmacol 1995: 50: 465.
53. WALLNER BP, MATTALIANO RJ, HESSION C, CATE RL, TIZARD R, SINCLAIR LK, FOELLER C, CHOW EP, BROWNING JL, RAMACHANDRAN KL, PEPINSKY RB. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 1986: 320: 77.
54. ALMAWI WY, SAOUDA MS, STEVENS AC, LIPMAN ML, BARTH CM, STROM TB. Partial mediation of glucocorticoid anti-proliferative effects by lipocortins. J Immunol 1996: 156: 5231.
55. ALMAWI WY, IRANI-HAKIME N. Glucocorticoid anti-proliferative effect: is it related to induction of TGF-β? Nephrol Dial Transplant 1998: 13: 2450.
56. AYANLAR-BATUMAN O, FERRERO AP, DIAZ A, JIMENEZ SA. Regulation of transforming growth factor-beta 1 expression by glucocorticoids in normal human T lymphocytes. J Clin Invest 1991: 88: 1574.
57. REYES-MORENO C, FRENETTE G, BOULANGER I, LAVERGNE E, GOVINDAN MV, KOUTSIEIERIS M. Mediation of glucocorticoid receptor function by transforming growth factor beta 1 expression in human PC-3 prostate cancer cells. Prostate 1995: 26: 260.
58. MOSMANN TR, CHERVINSHI H, BOND MW, GIEDLIN MA, COFFMAN RL. Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986: 136: 2348.
59. MACATONIA SE, DOHERTY TM, KNIGHT SC, O'GARRA A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production. J Immunol 1993: 150: 3755.
60. DUNCAN DD, SWAIN SL. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur J Immunol 1994: 24: 2506.
61. SCHMITZ J, ASSENMACHER M, RADBRUCH A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol 1993: 23: 191.
62. LOHOFF M, SCHMITT T, RESKE-KUNZ AB, ROLLINGHOFF M. Differential response of Th1 cells for stimulation with anti-CD3 antibodies. Eur J Immunol 1990: 20: 653.
63. MOSMANN TR, COFFMAN RL. Th1 and Th2 cells. Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989: 7: 145.
64. SAD S, MOSMANN TR. Single IL-2 secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 1994: 153: 3514.
65. SWAIN SL, WEINBERG AD, ENGLISH M, HOUSTON G. IL-4 directs the development of Th2-like helper functions. J Immunol 1990: 145: 3796.
66. PALM N, GERMANN T, GOEDERT S, HOEHN P, KOELSCH S, RUDE E, SCHMITT E. Co-development of naive CD4+ cells towards at helper type 1 or T helper type 2 cells induced by a combination of IL-12 and IL-4. Immunobiol 1996-1997: 196: 475.
67. HEINZEL FP, SADICK MD, MUTHA SS, LOCKSLEY RM. Production of interferon γ, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991: 88: 7011.
68. KELSO A. Th1 and Th2 subsets: paradigms lost? Immunol Today 1995: 16: 374.
69. PICOTTI JR, CHAN SY, GOODMAN RE, MAGRAM J, EICHWALD EJ, BISHOP DK. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol 1996: 157: 1951.
70. PICOTTI JR, CHAN SY, VANBUSKIRK AM, EICHWALD EJ, BISHOP DK. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 1997: 63: 619.
71. VANBUSKIRK AM, WAKELY ME, OROSZ CC. Transfusion of polarized Th2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation 1996: 62: 229.
72. HSIEH C-S, MACATONIA SE, TRIPP CS, WOLF SF, O'GARRA A, MURPHY KM. Development of Th1 CD4+ T cells through IL-12 produced by Listeria induced macrophages. Science 1993: 260: 547.
73. H cells. J Exp Med 1993: 177: 1199.
74. XU B, AOYAMA K, KITANI A, YU S, MATSUYAMA T, MATSUSHITA T. Interleukin-12 enhances contact hypersensitivity by modulating the in vivo cytokine pattern in mice. J Interferon Cytokine Res 1998: 18: 23.
75. RULIFSON IC, SPERLING AI, FIELDS PE, FITCH FW, BLUESTONE JA. CD28 costimulation promotes the production of Th2 cytokines. J Immunol 1997: 158: 658.
76. SWAIN SL. IL-4 dictates T-cell differentiation. Res Immunol 1993: 144: 616.
77. SZABO SJ, DIGHE AS, GUBLER U, MURPHY KM. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997: 185: 817.
78. NICKERSON P, STEIGER J, ZHENG XX, STEELE AW, STEURER W, ROY-CHAUDHURY P, STROM TB. Manipulation of cytokine networks in transplantation. False hope or realistic opportunity for tolerance? Transplantation 1997: 63: 489.
79. TANAKA T, HU-LI J, SEDER RA, GROTH B, PAUL WE. Interleukin 4 suppresses interleukin 2 and interferon-γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci USA 1993: 90: 5914.
80. COGAN E, SCHANDENE L, CRUSIAUX A, COCHAUX P, VELU T, GOLDMAN M. Clonal proliferation of type 2 helper T cells in a man with the hyper-eosinophilic syndrome. N Engl J Med 1994: 24: 535.
81. ROMAGNANI S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994: 12: 227.
82. DE WAAL-MALEFYT R, YSSEL H, DE VRIES JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993: 150: 4754.
83. FOWELL D, MCKNIGHT AJ, POWRIE F, DYKE R, MASON D. Subsets of CD4+ T cells and their role in the induction and prevention of autoimmunity. Immunol Rev 1991: 123: 37.
84. BALASA B, SARVETNICK N. The paradoxical effect of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmun 1996: 9: 283.
85. ROTI-IE H, FAUST A, SCHADE U, KLEEMANN R, BOSSE G, HIBINO T, MARTIN S, KOLB J. Cyclophosphamide treatment of female non-obese diabetic mice cause enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not interleukin-4. Diabetologia 1994: 37: 1154.
86. MUELLER R, DAVIES ID, KRAHL T, SARVETNICK N. IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection. J Immunol 1997: 159: 1599.
87. TIAN L, STEPKOWSKI SM, QU X, WANG ME, WANG M, YU J, KAHAN BD. Cytokine MRNA expression in tolerant heat allografts after immunosuppression with cyclosporin, sirolimus or brequinar. Transpl Immunol 1997: 5: 189.
88. STANULIS ED, JORDAN SD, ROSECRANS JA, HOLSAPPLE MP. Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone. Immunopharmacol 1997: 37: 25.
89. LACIER B, LEBEL B, BOUSQUET J, PENE J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-gamma) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 1997: 108: 545.
90. BLOTTA MH, DEKRUYFF RH, UMETSU DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997: 158: 5589.
91. RAMIREZ F, FOWELL D, PUKLAVEC M, SIMMONDS S, MASON D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 1996: 156: 2406.
92. ARANEO BA, DOWELL T, MOON T, DAYNES RA. Regulation of murine lymphokine production in vivo. Untraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism. J Immunol 1989: 143: 1737.
93. DAYNES RA, ARANEO BA. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989: 19: 2319.
94. DAYNES RA, ARANEO BA, DOWELL TA, HUANG K, DUDLEY D. Regulation of murine lymphokine production in vivo. II. The lymphoid tissue micro-environment exerts regulatory influences over T helper cell function. J Exp Med 1990: 171: 979.
95. MOYNIHAN JA, KARP JD, COHEN N, COCKE R. Alterations in interleukin-4 and antibody production following pheromone exposure: role of glucocorticoids. J Neuroimmunol 1994: 54: 51.
96. FLESHNER M, BRENNAN FX, NGUYEN K, WATKINS LR, MAIER SF. RU-486 blocks differentially suppressive effect of stress on in vivo anti-KLH immunoglobulin response. Am J Physiol 1996: 271: R1344.
97. WEBSTER EL, ELENKOV LJ, CHROUSOS GP. The role of corticotropin-releasing hormone in neuroendocrine-immune interactions. Mol Psychiatry 1997: 2: 368.
98. LEUNG DY, MARTIN RJ, SZEFLER SJ, SHER ER, YING S, KAY AB, HAMID Q. Dysregulation of interleukin-4, interleukin-5, and interferon-7 gene expression in steroid-resistant asthma. J Exp Med 1995: 181: 33.
99. NASEER T, MINSHALL EM, LEUNG DY, LABERGE S, ERNST P, MARTIN RJ, HAMID Q. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Resp Crit Care Med 1997: 15: 845.
100. CHIZZOLINI C, CHICHEPORTICHE R, BURGER D, DAYER JM. Human Th1 cells preferentially induce interleukin (IL)-1 beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes. Eur J Immunol 1997: 27: 171.
101. FENTON MJ, BURAS JA, DONNELLY RP. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol 1992: 149: 1283.
102. KOVALOVSKY D, PEREDA MP, SAUER J, PEREZ CASTRO C, NAHMOND VE, STALLA GK, HOLSBOER F, ARZT E. The Th1 and Th2 eytokines IFN-γ and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1. Eur J Immunol 1998: 28: 2075-2085.
103. VANNIER E, MILLER LC, DINARELLO CA. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but upregulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992: 89: 4076.
104. ORISS TB, MCCARTHY SA, MOREL BF, CAMPANA MA, MOREE PA. Cross-regulation between T helper cell (Th) 1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. J Immunol 1997: 158: 3666.
105. MUNOZ E, BEUTNER U, ZUBIAGA A, HUBER BT. IL-1 activates two separate signal transduction pathways in T helper type II cells J Immunol 1990: 144: 964.
106. GREENBAUM LA, HOROWITZ JB, WOODS A, PASQUALINI T, REICH EP, BOTTOMLY K. Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells. J Immunol 1988: 140: 1555.
107. ALLEN JB, WONG HL, COSTA CL, BIENKOWSKI MJ, WAHL SM. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 1993: 151: 4344.
108. BLISS J, VAN CLEAVE V, MURRAY K, WIENCIS A, KETCHUM M, MAYLOR R, HAIRE T, RESMINI C, ABBAS AK, WOLF SF. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J Immunol 1996: 156: 887.
109. ROGGE L, BARBERIS-MAINO L, BIFFI M, PASSINI N, PRESKY DH, GUBLER U, SINIGAGLIA F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997: 185: 825.
110. PANINA-BORDIGNON P, MAZZEO D, LUCIA PD, D'AMBROSIO D, LANG R, FABBRI L, SELF C, SINIGAGLIA F. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 1997: 100: 1513.
111. RAMER-QUINN DS, BAKER RA, SANDERS VM. Activated T helper 1 and T helper 2 cells differentially express the beta2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol 1997: 159: 4857.
112. ELENKOV LJ, PAPANICOLAOU DA, WILDER RL, CHROUSOS CP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Phys 1996: 108: 374.
113. MAIER B, BUHRING HJ, SIMON M, EICHMAN K, MELCHERS I. Limiting dilution analysis of proliferation and helper T cells in the in vivo immune response to KLH: depression of helper T class at moderately increased frequencies. J Mol Cell Immunol 1986: 2: 293.
114. BYRON KA, VARIGOS G, WOOTON A. Hydrocortisone inhibition of human interleukin-4. Immunol 1992: 77: 624.
115. KROUWELS FH, VAN DER HEIJDEN JF, LUTTER R, VAN NEERVEN RJ, JANSEN HM, OUT TA. Glucocorticosteroids affect functions of airway-and blood-derived human T cell clones, favoring the Th1 profile through two mechanisms. Am J Respir Cell Mol Biol 1996: 14: 388.
116. KUNICKA JF, TALLE MA, DENHARDT GH, BROWN M, PRINCE LA, GOLDSTEIN G. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell Immunol 1993: 149: 39.
117. BRAUN CM, HUANG SK, BASHIAN GG, KAGEY-SOBOTKA A, LICHTENSTEIN LM, ESSAYAN DM. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J Allergy Clin Immunol 1997: 100: 400.
118. UMLAND SP, NAHREBNE DK, RAZAC S, BEAVIS A, PENNLINE KJ, EGAN RW, BILLAH MM. The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells. J Allergy Clin Immunol 1997: 100: 511.
119. CHANG J-F, THOMAS CA, KUNG JT. Mitogen-induced IL-2 production and proliferation at defined stages of T helper cell development. J Immunol 1991: 147: 860.
120. GRABSTEIN K, DOWER S, GILLIS S, URDAL D, LARSEN A. Expression of interleukin 2, interferon-γ, and the IL-2 receptor by human peripheral blood lymphocytes. J Immunol 1986: 136: 4503.
121. ALMAWI WY, TAMIM H, AZAR ST. T helper type I and type II cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J Clin Endocrinol Metabol 1999: 84: 1497-1502.